[Influence of nitrofurantoin on blood coagulation and fibrinolysis in pregnancy, puerperium and newborn infant].
D001777:Blood Coagulation / Q000187:drug effects*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006207:Half-Life; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009582:Nitrofurantoin / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D010958:Plasminogen / Q000032:analysis; D049590:Postpartum Period; D011247:Pregnancy; D013916:Thrombelastography; D014552:Urinary Tract Infections / Q000188:drug therapy
D005340:Fibrinogen; D010958:Plasminogen; D009582:Nitrofurantoin
Einfluss von Nitrofurantoin auf die Blutgerinnung und Fibrinolyse der Schwangeren, Wöchnerinnen und Neugeborenen.